SNUG01

SNUG01 · SineuGene Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SNUG01, covering 2024-10-16 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS [Phase 1, Phase 2]